Vesalius Biocapital Partners S.à R.L.

Vesalius Biocapital Partners S.à r.l. is a venture capital and private equity firm specializing in investments in all stages of development with a focus on incubation, seed, start-up, early stage, mid venture, late venture, mid-stage, later stage, expansion, development capital, replacement, emerging growth, bridge financing, and corporate spin-offs with more mature assets. The firm invests in life sciences and novel food applications. Within life sciences, it invests in healthcare, pharmaceuticals, therapeutics, medtech, biotechnology, and nanotechnology. It invests in companies developing novel drugs, medical devices and diagnostics for unmet medical needs and also targets novel nutrition technologies which have the potential to prevent or cure disease. The firm prefers to invest in Europe with a focus on the Benelux countries including Belgium, Netherlands, and Luxembourg; German-speaking countries; Finland; Denmark; Flanders; France; Sweden; Norway; Iceland; Switzerland; Austria; Scandinavia; and the United Kingdom. It typically invests between €1 million ($1.23 million) and €5 million ($6.15 million) in its portfolio companies, with a maximum of €10 million ($12.31 million) over several rounds of financing. The firm usually takes minority equity stakes in its portfolio companies and also provides shareholder loans. It typically leads or co-leads the investment syndicate and always takes a board seat in its portfolio companies. Vesalius Biocapital Partners S.à r.l. is based in Strassen, Luxembourg.